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Introduction
Synapse assembly, maturation, validation, and maintenance are 
thought to depend on trans-synaptic cell adhesion molecules, 
including neurexins, neuroligins (NLs), and leucine-rich repeat 
transmembrane proteins (LRRTMs; Ushkaryov et al., 1992; 
Ichtchenko et al., 1995; Laurén et al., 2003). Four NLs are ex-
pressed  throughout  the  brain  but  are  differentially  targeted 
within neurons to specific synapses. NL1 is specific for ex-
citatory and NL2 for inhibitory synapses, whereas NL3 appears 
to be present in both types of synapses, and NL4 is expressed at 
low levels in as yet uncharacterized locations (Song et al., 1999; 
Graf et al., 2004; Varoqueaux et al., 2004, 2006; Budreck and 
Scheiffele, 2007). LRRTMs are also produced from four genes but 
with distinct regional expression patterns (Laurén et al., 2003). 
For example, the CA1 region of the hippocampus expresses only 
LRRTM1 and LRRTM2 at significant levels, whereas the dentate 
gyrus produces all four LRRTM isoforms (Laurén et al., 2003). 
Interestingly, NL1, NL3, NL4, and LRRTM3 have been impli-
cated in autism (Südhof, 2008; Sousa et al., 2010), and LRRTM1 
has been linked to schizophrenia (Francks et al., 2007).
NLs and LRRTMs both potently increase synapse density 
when overexpressed in neurons, suggesting that they are in-
volved in synapse formation or maintenance (Chih et al., 2005; 
Chubykin et al., 2007; Ko et al., 2009a,b). LRRTMs bind to 
presynaptic neurexins, raising the intriguing possibility that 
LRRTMs and NLs might be redundant postsynaptic neurexin 
ligands for trans-synaptic cell adhesion (de Wit et al., 2009;   
Ko et al., 2009b; Siddiqui et al., 2010). Moreover, single short 
hairpin RNA (shRNA)–dependent knockdowns (KDs) of indi-
vidual NLs and of LRRTM2 were reported to cause significant 
synapse loss (Chih et al., 2005; de Wit et al., 2009), indicating 
that NLs and LRRTMs are both separately required to initiate 
synapse formation. Surprisingly, however, deletion of NLs in 
N
euroligins (NLs) and leucine-rich repeat trans-
membrane proteins (LRRTMs) are postsynaptic 
cell  adhesion  molecules  that  bind  to  presyn-
aptic neurexins. In this paper, we show that short hair-
pin  ribonucleic  acid–mediated  knockdowns  (KDs)  of   
LRRTM1, LRRTM2, and/or NL-3, alone or together as dou-
ble or triple KDs (TKDs) in cultured hippocampal neurons, 
did not decrease synapse numbers. In neurons cultured 
from NL-1 knockout mice, however, TKD of LRRTMs and 
NL-3 induced an 40% loss of excitatory but not inhibi-
tory synapses. Strikingly, synapse loss triggered by the 
LRRTM/NL deficiency was abrogated by chronic block-
ade of synaptic activity as well as by chronic inhibition of 
Ca
2+ influx or Ca
2+/calmodulin (CaM) kinases. Further-
more, postsynaptic KD of CaM prevented synapse loss 
in a cell-autonomous manner, an effect that was reversed 
by CaM rescue. Our results suggest that two neurexin   
ligands, LRRTMs and NLs, act redundantly to maintain ex-
citatory synapses and that synapse elimination caused by   
the absence of NLs and LRRTMs is promoted by synaptic   
activity  and  mediated  by  a  postsynaptic  Ca
2+/CaM- 
dependent signaling pathway.
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single,  double,  or  triple  knockout  (KO)  mice  or  deletion  of 
LRRTM1 in single KO mice failed to produce significant syn-
apse loss (Varoqueaux et al., 2006; Linhoff et al., 2009). This 
finding, together with the observation that the synapse-boosting 
effect of overexpressed NLs requires synaptic activity (Chubykin 
et al., 2007), prompted an alternative hypothesis, namely that 
NLs and LRRTMs function as signaling molecules that trans-
late synaptic activity into synapse maintenance (i.e., validate 
synapses; Südhof, 2008).
Here, we systematically tested the effects of decreased 
LRRTM and NL expression on synapse numbers in cultured 
hippocampal neurons. Consistent with the KO results, we find 
that individual or combined KDs of the two LRRTMs that are 
highly expressed in the hippocampus (LRRTM1 and LRRTM2) 
or KD of NL3 alone did not decrease synapse numbers in wild-
type neurons. However, the combined triple KD (TKD) of 
LRRTM1, LRRTM2, and NL3 in NL1 KO neurons caused a   
robust decline in excitatory synapse density. This synapse loss 
was reversed by reexpression of full-length NL1 or LRRTM2 as 
well as by expression of the extracellular regions of NL1 or 
LRRTM2. Importantly, both the increases in synapse numbers 
by gain-of-function and the decreases in synapse numbers by 
loss-of-function  manipulations  of  NLs  and  LRRTMs  were 
counteracted  by  blocking  synaptic  activity.  Collectively, 
these results suggest that NLs and LRRTMs cooperate to 
maintain normal levels of excitatory synapses in an activity-
dependent manner and that neurexins are presynaptic hub 
molecules  that  coordinate  postsynaptic  signals  from  inde-
pendent ligands.
Results
Lentiviral KDs of LRRTMs or NL3 do not 
suppress synapse numbers
To identify effective shRNAs for KD of LRRTM1, LRRTM2, 
and NL3, we expressed shRNAs in cultured mouse cortical neu-
rons using lentiviruses and quantified endogenous target mRNA 
levels by real-time RT-PCR (Figs. 1 A and S1). We identified 
shRNAs that suppress endogenous mRNAs for LRRTM1 by 
90% (J14), for LRRTM2 by 75% (J17, J18, and J33), and 
for NL3 by 95% (J50; Fig. 1 B). Moreover, we confirmed that 
the NL3 shRNA severely suppressed NL3 protein expression 
(Fig. S1), although we could not measure LRRTM protein levels 
because of a lack of LRRTM antibodies.
Next, we investigated whether single KD of LRRTM1, 
LRRTM2, or NL3 alters synapse density in cultured neurons. 
We transfected cultured hippocampal neurons at day in vitro 3 
(DIV3) with vectors that express only EGFP (control) or coexpress  Figure 1.  Single KDs of LRRTMs or NLs do not alter synapse density in 
cultured neurons. (A) Design of lentiviral shRNA vectors for KD of LRRTM1, 
LRRTM2, or NL3. H1, human H1 promoter; IRES, internal ribosome entry 
sequence; Ub, ubiquitin promoter. (B) Levels of target mRNAs (LRRTM1, 
LRRTM2, and NL3) measured by quantitative RT-PCR in cultured cortical   
neurons  infected  at  DIV3  with  lentiviruses  expressing  the  indicated   
shRNAs. mRNAs were determined at DIV12 and 13. Dashed line, 75% KD 
cutoff level for tests of biological effects. (C) Representative images of cul-
tured hippocampal neurons that were transfected at DIV3 with lentiviral 
vector lacking shRNA expression (control) or expressing shRNAs targeting 
LRRTM1 (J14), LRRTM2 (J18 and J33), or NL3 (J50). Neurons were ana-
lyzed at DIV14 by double immunofluorescence with antibodies to GFP and 
vGLUT1. WT, wild type. Bar, 5 µm. (D) A summary graph of the effects of 
single KD of LRRTM1, LRRTM2, and NL3 on excitatory synapse density, quanti-
fied using vGLUT1 immunoreactivity. The dotted line represents a control level 
of synapse density for comparisons with the other experimental conditions.   
(B and D) The shaded gray and blue bars represent the results with the non-
effective and effective shRNA vectors, respectively. The data shown are 
means ± SEMs (n = 3 independent culture experiments). Statistical signifi-
cance was assessed by comparing the various conditions with controls using 
the ANOVA Tukey’s test. *, P < 0.05. For further data, see Figs. S1 and S2.
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EGFP with shRNAs against LRRTM1, LRRTM2, or NL3. 
We  immunostained  the  transfected  neurons  at  DIV14  for 
vGLUT1, an excitatory presynaptic marker, and quantified 
the density and size of excitatory synapses on dendrites of the 
transfected neurons (Figs. 1 [C and D] and S2). None of the 
shRNAs decreased the excitatory synapse density, except for 
one of the LRRTM2 shRNAs (J33). Similar results were ob-
tained when we infected hippocampal neurons with lenti-
viruses expressing shRNAs at DIV3 or when we transfected 
cultured hippocampal neurons at DIV9 (Fig. S2, A and B). 
The J33 shRNA, which was the only shRNA that by itself 
decreased synapse density, is identical to an shRNA used 
previously to demonstrate that the LRRTM2 KD decreases 
synapse numbers (de Wit et al., 2009), thus confirming these 
results.  However,  other  LRRTM2  shRNAs  that  produce  a 
similar KD of LRRTM2 expression did not change synapse 
numbers (Fig. 1 B), suggesting that the J33 effect may be 
mediated by an off-target mechanism (Alvarez et al., 2006).
KD of both LRRTMs and NL3 in  
NL1 KO neurons reduces excitatory  
synapse numbers
We next generated expression vectors that contain four human 
polymerase III promoters (to express shRNAs) and a ubiquitin 
promoter  (to  express  EGFP  for  visualization  of  infected  or 
transfected neurons; Fig. 2 A). We then suppressed expression 
of LRRTM1 and LRRTM2 with this vector (denoted as LRRTM 
double KD [DKD]; note that the two LRRTM2 shRNAs with-
out off-target effects [J17 and J18] were used together here to 
increase the KD efficiency). For simultaneous KD of LRRTMs 
and NL3, we additionally introduced the NL3 shRNA into the 
DKD vector and found that mRNA levels of all three proteins 
(LRRTM1, LRRTM2, and NL3) were successfully suppressed 
(denoted as TKD; Fig. 2, A and B).
target mRNA levels (LRRTM1, LRRTM2, and NL3) in cultured cortical neu-
rons as described in Fig. 1 B, except that neurons were infected with DKD 
lentiviruses expressing shRNAs to LRRTM1 and LRRTM2 or TKD lentiviruses 
that additionally express an shRNA to NL3. The target mRNA measured 
is color coded as indicated on the right. Dashed line, 75% KD cutoff level 
for tests of biological effects. (C) Representative images of hippocampal 
neurons cultured from wild-type (WT) or NL1 KO mice that were trans-
fected with the indicated KD vectors at DIV9 and analyzed by double 
immunofluorescence with antibodies to GFP and synapsin at DIV14. For 
transfections at DIV3, see Fig. S2. Bar, 5 µm. (D) Summary graphs of the 
effect in wild-type (left) or NL1 KO neurons (right) of the LRRTM DKD, the 
NL3 KD, and the combined LRRTM1, LRRTM2, and NL3 TKD on overall 
synapse densities, quantified using synapsin immunoreactivity. (E) Sum-
mary graphs of the effect of the LRRTM1, LRRTM2, and NL3 TKD in NL1 
KO neurons on the density of excitatory synapses (measured using vGLUT1 
or PSD-95 as markers) or inhibitory synapses (using vGAT as a marker) 
determined at DIV14 (left) or of the effect of the TKD on excitatory synapse 
density monitored with vGLUT1 as a marker after longer culture times, 
comparing DIV14 with DIV17 and DIV20 (right). (B, D, and E) The dotted 
lines represent control levels for comparisons with the other experimental 
conditions. The data shown are means ± SEMs (n = 3 independent culture 
experiments). Statistical significance was assessed by comparing the vari-
ous conditions with controls using the ANOVA Tukey’s test. *, P < 0.05. For 
additional images and synapse size quantitations and different variations 
of the KD experiments, see Figs. S2 and S3. For analysis of the TKD effect 
on neuronal morphology and differentiation, see Fig. S3.
 
Figure 2.  Combined loss of function of LRRTM1, LRRTM2, NL1, and NL3 
causes synapse loss. (A) Design of lentiviral shRNA vectors for simultane-
ous KD of multiple targets using the indicated shRNAs. H1 and U6, human 
H1 and U6 promoters; Ub, ubiquitin promoter. Note that two LRRTM2 
shRNAs (J17 and J18) were used simultaneously for efficient KD; J33 was 
excluded because of its apparent off-target effect. (B) Measurements of JCB • VOLUME 194 • NUMBER 2 • 2011   326
(Graf et al., 2004; Varoqueaux et al., 2004; Chubykin et al., 2007; 
Poulopoulos et al., 2009), and NL4 is expressed only at very 
low levels (Varoqueaux et al., 2006).
Strikingly, neither the DKD of LRRTM1 and LRRTM2 
nor the TKD of these LRRTMs together with NL3 significantly 
decreased synapse numbers in wild-type hippocampal neurons 
Using the DKD and TKD vectors, we examined whether 
LRRTMs alone or together with NL3 are essential for synapse 
maintenance. To include NL1 in our analysis, we additionally 
performed all experiments in neurons cultured from NL1 KO 
mice (Varoqueaux et al., 2006). We did not include NL2 and 
NL4 in this study because NL2 localizes to inhibitory synapses 
Figure 3.  Reversal of synapse loss by overexpression of LRRTM2 
or NL1 in LRRTM/NL-deficient neurons. (A) Diagrams of proteins 
expressed from shRNA-resistant transcripts in neurons. Full-length 
proteins contain an mVenus tag in the cytoplasmic tail; two splice 
variants of NL1 containing or lacking inserts in splice sites A 
and B (Boucard et al., 2005) were used as indicated. NL1-32 
carries point mutations that block neurexin binding (indicated by 
asterisks; Ko et al., 2009a). In pDis proteins, the transmembrane 
region (TMR) and cytoplasmic sequence of NL1 or LRRTM2 are 
replaced with the transmembrane region of the PDGF receptor 
(PDGFR). EHD, esterase homology domain; LRR, leucine-rich re-
peat; HA and Myc, HA and myc epitopes. (B) Representative 
images of cultured hippocampal neurons from NL1 KO mice 
that were transfected with vectors expressing EGFP alone (con-
trol) or together with the indicated shRNAs (TKD; triple LRRTM1, 
LRRTM2, and NL3 KD). shRNA vectors were cotransfected at 
DIV9 with plasmids encoding the indicated proteins. Neurons 
were analyzed by double immunofluorescence with antibodies 
to GFP and vGLUT1 at DIV14. Bar, 5 µm. (C) Summary graphs 
of synapse densities. The dotted lines represent control levels for 
comparisons with the other experimental conditions. The data 
shown are means ± SEMs (n = 3 independent culture experi-
ments). Statistical significance was assessed by comparing the 
various conditions with controls using the ANOVA Tukey’s test. 
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that  still  express  endogenous  NL1  (Fig.  2,  C  and  D).  More-
over, expression of only the extracellular sequences of NL1 or 
LRRTM2 also reversed the TKD phenotype in NL1 KO neurons 
and restored the density of vGLUT1- and PSD-95–containing 
synapses to control levels (Fig. 3, B and C). Furthermore, an NL1 
mutant that lacks neurexin-binding activity (NL1-32) was still 
active. These results are consistent with previous observations 
that found when overexpressed, the extracellular region of NL1   
is sufficient to increase excitatory synapse density, as is the   
NL1-32 mutant (Chubykin et al., 2007; Ko et al., 2009a).
To determine whether the changes in anatomical synapse 
numbers reflect the changes in the number of functional synapses, 
we examined synaptic transmission in NL1 KO neurons that were 
infected with control viruses or the TKD viruses either alone or 
together with the NL1 or LRRTM2 expression vectors (Fig. 4). 
Measurements of 2-amino-3-(5-methyl-3-oxo-1,2,-oxazol-4-yl) 
propanoic acid (AMPA) and of N-methyl-d-aspartate (NMDA) 
receptor–mediated excitatory postsynaptic currents (EPSCs) 
using the protocol of Maximov et al. (2007) showed that the 
TKD caused a massive decrease in excitatory synaptic transmis-
sion, with both glutamate receptor components affected equally 
(Fig. 4, A and B). Expression of either NL1 or of LRRTM2   
reversed this impairment. In contrast, the TKD did not alter   
inhibitory postsynaptic currents (IPSCs), confirming its speci-
ficity (Fig. 4 C).
Synaptic activity is required for synapse 
loss in LRRTM/NL-deficient neurons
Because  chronic  inhibition  of  NMDA  receptors  or  of  Ca
2+/ 
CaM-dependent kinase (CaM kinase) suppresses the synapse-
boosting activities of overexpressed NL1 in cultured neurons 
(Chubykin et al., 2007), we next explored whether a similar   
activity dependence applies to the synapse-boosting effect of 
overexpressed LRRTM2. We transfected neurons at DIV10 
with expression vectors encoding mVenus (control), mVenus-
fused NL1
AB (lacking inserts in splice sites A and B), and 
(Figs. 2 [C–E] and S2). When we introduced the DKD into NL1 
KO neurons (which also exhibit no synapse loss), we observed 
a small but nonsignificant decrease in synapse numbers. Only 
introduction of the LRRTM/NL TKD into NL1 KO neurons 
caused a robust decrease in synapse density (40–50%, de-
pending on whether pre- or postsynaptic markers were ana-
lyzed; Fig. 2, C–E) without changing the size, dendrite length, 
or dendritic branching of the neurons (Fig. S3, A and B). The 
synapse loss in NL1 KO neurons expressing the TKD plasmids 
was specific for excitatory synapses (Fig. 2 E), consistent with 
the selective effects of the targeted proteins in gain-of-function 
assays (de Wit et al., 2009; Ko et al., 2009b). In our culture sys-
tem, neurons continue to form synapses until at least 3 wk in vitro. 
The TKD-induced synapse loss in NL1 KO neurons was ob-
served independent of the age of the culture (Figs. 2 E and S3 
[C and D]) and could reflect diminished synapse formation   
and/or increased synapse elimination. Together, these results 
suggest that LRRTMs and NLs redundantly maintain excitatory 
synapses in cultured hippocampal neurons. Note that, in these 
experiments, the analyzed neurons represent a small subset of 
all neurons that are surrounded by nontransfected neurons; thus, 
the KD neurons compete with control neurons for synaptic   
inputs. However, the same results were obtained for LRRTM 
DKDs in experiments in which neurons were infected with lenti-
viruses expressing the KD shRNAs, and, thus, no competition 
between neurons for synaptic inputs exists (Fig. S2 B).
Reversal of the TKD phenotype in NL1 KO 
neurons by LRRTM2 or NL1 independent 
of their intracellular sequences
Next, we cotransfected into NL1 KO neurons the TKD plasmid   
with plasmids encoding full-length NL1 or LRRTM2 or their   
extracellular sequences fused to the PDGF receptor transmem-
brane region (Fig. 3 A). Expression of both full-length NL1 or 
LRRTM2 restored excitatory synapse numbers (Fig. 3, B and C), 
explaining the lack of a TKD phenotype in wild-type neurons   
Figure 4.  Combined loss of function of LRRTM1, LRRTM2, NL1, and NL3 selectively impairs excitatory synaptic transmission: reversal by overexpression 
of LRRTM2 or NL1. (A) Representative traces (left) and summary graphs of the amplitudes (right) of evoked AMPA receptor–mediated EPSCs in NL1 KO 
neurons infected with lentiviruses that express only EGFP (control) and coexpress EGFP with the LRRTM1, LRRTM2, and NL3 shRNAs without (TKD) or with 
coexpression of either NL1 containing inserts in splice sites A and B (+NL1
AB) or of LRRTM2 (+LRRTM2). (B) Same as A, except that evoked NMDA recep-
tor–mediated EPSCs were measured. (C) Same as A, except that evoked IPSCs were measured, and only the control and TKD conditions were examined 
because the TKD had no effect on inhibitory responses. (A–C) The dotted lines represent control levels for comparisons with the other experimental condi-
tions. The data shown are means ± SEMs (numbers in bars = numbers of cells/cultures analyzed). Statistical significance was assessed by comparing the 
various conditions with controls using unpaired, two-tailed Student’s t tests. ***, P < 0.001.JCB • VOLUME 194 • NUMBER 2 • 2011   328
the synapse loss caused by the TKD in NL1 KO neurons, indi-
cating that the spontaneous synaptic activity in our cultures is 
sufficient to drive synapse elimination (Fig. S4, B and C).
In further experiments, we systematically tested specific 
receptor antagonists to identify the receptor activity that under-
lies the loss of synapses caused by NL and LRRTM KDs. 
Chronic treatment of control- or TKD-transfected NL1 KO neu-
rons with DMSO (as a solvent control), APV, NBQX, picrotoxin, 
or LY341495 revealed that only the AMPA receptor antagonist 
NBQX prevented synapse loss in TKD neurons, whereas APV 
exerted a partial effect (Fig. 6, C and D). Conversely, tetrodo-
toxin (TTX), which selectively inhibits action potentials, was 
ineffective in blocking synapse loss, suggesting that spontane-
ous mini release is sufficient to activate synapse elimination in 
LRRTM/NL-deficient neurons. We observed no significant 
changes in synapse number in control neurons treated with indi-
vidual drugs and no changes in synapse size under any condi-
tion tested (Fig. S5 A).
Activity-dependent synapse loss in LRRTM/
NL-deficient neurons requires Ca
2+ influx, 
CaM, and CaM kinase activity
A common mechanism by which activity influences synapse 
function is via Ca
2+ and its downstream targets, such as CaM 
kinases  (Wayman  et  al.,  2008).  Therefore,  we  explored  the 
hypothesis that activity-dependent synapse loss may operate 
mVenus-fused LRRTM2. We subsequently treated the trans-
fected neurons from the time of transfection with either DMSO 
or a cocktail of neurotransmitter receptor inhibitors to block syn-
aptic activity  (a  mixture  of  dl-2-amino-5-phosphonovalerate 
[APV], 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinox-
aline-7-sulfonamide [NBQX], picrotoxin, and LY341495 [a type II 
metabotropic glutamate receptor antagonist]) and immunostained 
the neurons at DIV14. As previously described, overexpression 
of both NL1
AB and LRRTM2 increased excitatory synapse num-
bers and sizes (Boucard et al., 2005; de Wit et al., 2009; Ko et al., 
2009a,b). Upon blockade of synaptic activity, overexpression of 
NL1 and LRRTM2 was less effective in increasing synapse den-
sities and no longer increased synapse sizes (Fig. 5).
We then examined whether synapse elimination induced 
by the TKD in NL1 KO neurons is also dependent on synaptic 
activity. Chronic treatment of control NL1 KO neurons with the 
neurotransmitter receptor inhibitor cocktail had no effect on syn-
apse numbers, whereas the same treatment blocked the synapse 
loss induced by the TKD in NL1 KO neurons (Figs. 6 [A and 
B] and S4 A). These results were confirmed using both presyn-
aptic (vGLUT1) and postsynaptic marker proteins (NMDAR1 
and GluR2). Thus, both the increases in synapse numbers pro-
duced by NL1 or LRRTM2 overexpression and the decreases 
in synapse numbers produced by KD of LRRTMs and NL3 in 
NL1 KO neurons involve synaptic activity. Chronic stimulation 
of neurons by depolarization with 15 mM KCl did not increase 
Figure 5.  Activity-dependent synapse formation induced by   
overexpression of NL1 or LRRTM2 in neurons. (A) Representa-
tive images of cultured wild-type hippocampal neurons that 
were transfected at DIV10 with expression plasmids encoding 
mVenus (control) or mVenus fusion proteins of NL1 lacking 
inserts in splice sites A and B (NL1
AB) or of LRRTM2 and 
analyzed at DIV14 by double immunofluorescence with anti-
bodies to GFP and vGLUT1. DMSO (negative control) or a   
cocktail of blockers for all neurotransmitter receptors (50 µM 
APV + 20 µM NBQX + 50 µM picrotoxin + 10 µM LY341495)   
was added to the cultured neurons at the time of transfection 
to block synaptic activity. Bar, 5 µm. (B) Summary graphs of   
the effect of the synaptic activity blockers on synapse den-
sity and synapse size in transfected neurons, quantified by 
vGLUT1 staining. The dotted lines represent control levels for 
comparisons with the other experimental conditions. The sta-
tistics in B were performed in comparison with DMSO-treated 
conditions, determined by the ANOVA Tukey’s test. *, P < 0.05; 
3*, P < 0.001.329 Neuroligin and LRRTM function in synapse elimination • Ko et al.
Figure 6.  Activity-dependent synapse elimination in LRRTM/NL-deficient neurons. (A) Representative images of hippocampal neurons from NL1 KO mice 
that were transfected at DIV9 with a vector expressing EGFP only (control) or coexpressing the TKD shRNAs and analyzed at DIV14 by double immunofluo-
rescence with antibodies to GFP and vGLUT1, NMDAR1, or GluR2 as indicated. Neurons were treated with DMSO (negative control) or a cocktail of block-
ers for all neurotransmitter receptors (50 µM APV + 20 µM NBQX + 50 µM picrotoxin + 10 µM LY341495) from the time of transfection to block synaptic 
activity. Only merged images are shown (vGLUT1, NMDAR1, or GluR2 in red and EGFP in green). See Fig. S5 for separate images. (B) A summary graph 
of the effects of the synaptic activity blockers on synapse density (top) and synapse size (bottom) in control and TKD neurons. (C) Representative images of 
hippocampal neurons from NL1 KO mice that were transfected at DIV9 with a vector expressing EGFP only (control) or coexpressing the TKD shRNAs and 
analyzed by double immunofluorescence with antibodies to GFP and vGLUT1 at DIV14. Neurons were treated separately with the agents indicated on the 
right (2 µM TTX, 50 µM APV, 20 µM NBQX, 50 µM picrotoxin, and 10 µM LY341495) and analyzed both by staining for surface-exposed postsynaptic 
GluR1 receptors (left) and for vGLUT1 (right). Only merged images are shown (surface GluR1 or vGLUT1 in red and EGFP in green). (D) Summary graphs 
of the effects of the LRRTM/NL TKD on synapse density as measured by staining for surface-exposed GluR1 and for vGLUT1 and of the effect of individual 
pharmacologic agents on the synapse loss produced by the TKD. (B and D) The dotted lines represent control levels for comparisons with the other experi-
mental conditions. The data shown are means ± SEMs (n = 3 independent cultures). Statistical significance was assessed by comparing the various condi-
tions with controls using the ANOVA Tukey’s test. *, P < 0.05; **, P < 0.01; ***, P < 0.001. For analyses of synapse sizes, see Fig. S5. Bars, 5 µm.JCB • VOLUME 194 • NUMBER 2 • 2011   330
via a Ca
2+-dependent pathway involving CaM kinases that, in 
our cultured neurons, would be activated by AMPA receptor– 
dependent synaptic events. We found that inhibition of L-type 
Ca
2+ channels with nifedipine partly blocked the synapse loss 
induced by the LRRTM/NL TKD in NL1 KO neurons, whereas 
inhibition of both L-type Ca
2+ channels and NMDA receptors 
completely abrogated the synapse loss (Figs. 7 [A and B] and 
S5 C). Next, we treated control and TKD-transfected NL1 KO 
neurons with the active and inactive enantiomers of a CaM   
kinase inhibitor (KN-93 and KN-92, respectively, applied for 5 d)   
and quantified excitatory synapse numbers and sizes (Figs. 7   
[C and D] and S5 D). Indeed, chronic blockade of CaM kinase 
by KN-93 abolished the decrease in excitatory synapse density of 
LRRTM/NL-deficient neurons, whereas KN-92 had no effect.
The effects of the CaM kinase inhibitor may be a result of 
a specific inhibition of postsynaptic CaM kinases or of a general 
impairment of synaptic activity in the cultured neurons. To dif-
ferentiate between these two possibilities and to test whether a 
postsynaptic  cell-autonomous  Ca
2+/CaM-dependent  signaling 
pathway mediates synapse loss in LRRTM/NL-deficient neu-
rons, we cotransfected neurons with control plasmid or with 
TKD and CaM KD plasmids with or without wild-type CaM 
rescue vectors (see Pang et al., 2010a,b for a detailed descrip-
tion of the CaM KD methodology). Strikingly, KD of CaM 
abolished the synapse elimination elicited by the TKD of 
LRRTMs and NLs; this prevention of synapse loss in turn was 
reversed by expression of wild-type CaM (Figs. 7 [C and D] and 
S5 D). Because neurons are sparsely infected, CaM acts in a 
cell-autonomous manner. Thus, synapse elimination induced by 
loss of LRRTMs and NLs requires a postsynaptic CaM-dependent 
signaling pathway in the same neurons as those expressing the 
LRRTM and NL shRNAs.
Discussion
Studies over the last decade established that neurexins, NLs, and 
LRRTMs function as trans-synaptic cell adhesion molecules and 
that at least neurexins and NLs are essential for normal brain 
function (Missler et al., 2003; Chih et al., 2005; Varoqueaux 
et al., 2006; Linhoff et al., 2009). Moreover, the recent discovery 
Figure 7.  Synapse elimination produced by combined loss of function of 
LRRTM1, LRRTM2, NL1, and NL3 requires Ca
2+/CaM signaling. (A) Repre-
sentative images of hippocampal neurons from NL1 KO mice that were 
transfected at DIV9 with lentiviruses expressing either EGFP alone (con-
trol) or together with the TKD shRNAs and analyzed by double immuno-
fluorescence with antibodies to GFP and vGLUT1 at DIV14. Neurons were 
treated separately with the agents indicated on the right and analyzed with 
antibodies to GFP and vGLUT1. DMSO (negative control) or L-type calcium 
channel blocker and/or NMDA receptor antagonist (Nif = 10 µM nifedi-
pine; Nif + APV = 10 µM nifedipine + 50 µM APV) were added to the cul-
tured neurons at the time of transfection. Bar, 5 µm. (B) Summary graphs of 
the synapse density quantified in experiments as described in C. (C) Rep-
resentative images of hippocampal neurons from NL1 KO mice that were 
transfected at DIV9 with lentiviruses expressing either EGFP alone (control) 
or together with the TKD shRNAs and analyzed by double immunofluores-
cence with antibodies to GFP and vGLUT1 at DIV14. Neurons were treated 
from DIV9 on with DMSO or 5 µM KN-93 or KN-92 (active and inactive 
CaM kinase inhibitor enantiomers) or were cotransfected with CaM KD 
shRNAs without (CaM KD) or with coexpression of shRNA-resistant full-length 
CaM (CaM KD rescue; Pang et al., 2010a). Neurons were analyzed at 
DIV14. Bar, 5 µm. (D) Summary graphs of the synapse density quantified in 
experiments as described in C. (B and D) The dotted lines represent control 
levels for comparisons with the other experimental conditions. The data 
shown are means ± SEMs (n = 3 independent culture experiments). Statisti-
cal significance was assessed using the ANOVA Tukey’s test. *, P < 0.05; 
**, P < 0.01. For analyses of synapse sizes, see Fig. S5.
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the NL/LRRTM TKD in NL1 KO neurons indicates that the 
synapse loss occurs by active synapse elimination and not by 
lack of synapse formation. Thus, in our arguably most impor-
tant observation, the loss-of-function decrease in synapse num-
bers seen here is likely a reflection of a signaling function of 
LRRTMs and NLs that is required for maintaining normal syn-
apse numbers in active synapses but that is not operational   
in functionally silent synapses. However, because we globally 
blocked activity in the cultured neurons, we cannot conclude 
that under all conditions inactive synapses are protected and 
never eliminated after NL/LRRTM TKD in NL1 KO neurons. It 
is conceivable that if only subsets of synapses on a given cell 
remain active, other rules apply. (4) Finally, in an initial dissec-
tion of the signaling pathway involved, we found that inhibition 
of postsynaptic Ca
2+ influx, inhibition of CaM kinases, and spe-
cific postsynaptic KD of CaM all effectively blocked the syn-
apse elimination induced by the TKD in NL1 KO neurons. The 
panneuronal inhibition of CaM kinases may have operated 
by generally dampening synaptic activity, akin to other pro-
cedures blocking synaptic activity. However, the effective-
ness  of  the  CaM  KD  is  remarkable,  given  that  the  KD 
achieves only a partial suppression of CaM levels (70% 
decrease; Pang et al., 2010a,b) and that the KD was only 
present in the postsynaptic neurons that were also subject to 
the TKD. This result implies that Ca
2+-dependent postsynaptic 
activation of CaM is required for synapse elimination induced 
by the TKD in NL1 KO neurons. Stimulation of specific sets 
of transcription factors by postsynaptic CaM activation may 
trigger the TKD phenotype, but the mechanism involved re-
mains to be investigated.
At least three alternative models can be envisioned to 
account for our results. The first is a synaptic competition 
model whereby synapses normally compete for each other in 
an activity-dependent manner in a given neuron, limiting their 
number. This is the dominant model in current thinking to 
account for the developmental pruning of synapses and is well 
supported by extensive studies on neuromuscular and climb-
ing fiber synapses (Rabacchi et al., 1992; Nguyen and Licht-
man, 1996; Goda and Davis, 2003; Wyatt and Balice-Gordon, 
2003; Cesa and Strata, 2005). However, this model cannot ex-
plain our results because a block of synaptic activity itself has 
no effect on synapse numbers, as our results confirm exten-
sively. Thus, the relative loss of synapses we observe (be it be-
cause synapses are eliminated or don’t form; see discussion 
below) is not explained by roles for NLs and LRRTMs in syn-
aptic  competition,  although  this  finding  does  not  preclude 
such a role in more complex in vivo situations.
The  second  explanation  is  a  synapse  capacity  model 
whereby the amount of NLs and LRRTMs determines the num-
ber of synapses that are formed and maintained at any given 
time. The model agrees very well with the overall effects of 
increased and decreased LRRTM and NL expression on syn-
apse numbers. However, according to this model, the action 
of LRRTMs and NLs should be activity independent, which is 
not the case. In particular, the fact that blocking postsynaptic 
Ca
2+/CaM signaling blocks the effect of the LRRTM/NL loss of 
function on synapse numbers renders this model unlikely.
that both NLs and LRRTMs are postsynaptic ligands for pre-
synaptic neurexins suggested that NLs and LRRTMs act in at 
least partly overlapping pathways (de Wit et al., 2009; Ko et al.,   
2009b; Siddiqui et al., 2010). However, two different loss- 
of-function  approaches,  mouse  KOs  versus  RNAi-dependent 
KDs, provided starkly different conclusions about the function 
of neurexins, NLs, and LRRTMs. Mouse genetics showed that 
-neurexins and NLs are essential for survival not because these 
molecules mediate the establishment of synapses but because 
they are essential for the functional organization of synapses 
(Missler et al., 2003; Varoqueaux et al., 2006; Chubykin et al., 
2007; Gibson et al., 2009). RNAi experiments, conversely, sug-
gested that neurexins, NLs, and LRRTMs are separately es-
sential for the presence of synapses (Chih et al., 2005; de Wit 
et al., 2009). Each approach suffers from potential limitations. 
Whereas noninducible mouse mutants harbor the possibility of 
developmental compensation, RNAi results are rendered am-
biguous by off-target effects and suffer from the difficulty of 
achieving >80% KD efficiency. In the present study, we have 
asked  whether,  under  well-controlled  conditions  in  cultured 
neurons, acute loss of function of multiple LRRTMs and NLs 
alters the number of synapses and, if so, by which mechanism. 
In the latter question, we were guided by our earlier observation   
that NL1 overexpression increases synapse numbers by an 
activity-dependent pathway (Chubykin et al., 2007), which raised 
the possibility that NLs and LRRTMs, if they act analogously, 
may generally regulate synapse maintenance in an activity- 
dependent manner.
Thus, we asked whether the gain-of-function effects of 
LRRTMs are also activity dependent and whether loss-of-function 
effects for NLs and/or LRRTMs are analogously driven by syn-
aptic activity. We made four principal observations: (1) Single 
KDs of LRRTM1, LRRTM2, and NL3 had no significant effect 
on synapse numbers in cultured hippocampal neurons; even the 
combined DKD of LRRTM1 and LRRTM2 or the combined 
TKD of LRRTM1, LRRTM2, and NL3 did not alter synapse 
densities. Only the TKD of LRRTM1, LRRTM2, and NL3 
applied on the background of the NL1 KO produced a robust 
decrease in synapse numbers, suggesting that LRRTMs and NLs 
are functionally redundant, at least as manifested in synapse 
numbers. (2) Overexpression of either LRRTM2 or NL1 re-
versed the synapse loss induced by the TKD on the background 
of the NL1 KO. This reversal was also mediated by LRRTM2 
and NL1 mutants that lacked their normal transmembrane re-
gions and cytoplasmic tails, suggesting that the extracellular se-
quences of these molecules are sufficient for increasing synapse 
numbers under the TKD/NL1 KO condition. Note that although 
this experiment looks like a classical rescue experiment, it can-
not be interpreted as such because overexpression of these mol-
ecules increases synapse numbers in a gain-of-function manner. 
(3) Strikingly, synapse loss induced by the TKD in NL1 KO 
neurons was ablated by blocking synaptic activity in cultured 
neurons. We previously showed that activity blockade prevents 
the gain-of-function effect of overexpressed NL1 or NL2, but 
we were surprised that activity blockade also prevents the loss-
of-function effects observed here (Chubykin et al., 2007). The 
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Antibodies
The following antibodies were commercially purchased: monoclonal mouse 
antibody for MAP2 (Sigma-Aldrich), polyclonal guinea pig antibody for 
vGLUT1 (Millipore), polyclonal rabbit antibody for vesicular -aminobutyric 
acid transporter (VGAT; Millipore), monoclonal antibody for PSD-95 (clone 
7E3-1B8; Thermo Fisher Scientific), monoclonal antibody for NMDAR1 
(clone  M68;  Synaptic  Systems),  polyclonal  rabbit  antibody  for  GluR1 
(EMD), monoclonal antibody for GluR2 (clone 6C4; Millipore), mono-
clonal antibody for Rab–GDP dissociation inhibitor (clone 81.2; Synaptic   
Systems),  and  polyclonal  goat  antibody  for  GFP  (Rockland  Immuno-
chemicals for Research). Rabbit polyclonal synapsin antibody (E028), 
polyclonal NL3 antibody (528B), and polyclonal PSD-95 antibody (L667) 
were previously described (Irie et al., 1997; Chubykin et al., 2005;   
Tabuchi et al., 2007).
Generation of lentiviral shRNA plasmids
To construct the shRNA lentivirus expression vectors, the oligonucleotides 
targeting mouse LRRTMs (LRRTM1 and LRRTM2) or mouse NL3 were an-
nealed, phosphorylated, and subcloned into XhoI and XbaI sites of a 
single KD vector (see Fig. 1 A for the schematic diagram of vectors)   
immediately downstream of the human H1 promoter. For an LRRTM DKD, 
the oligonucleotides containing LRRTM1 (J14) and LRRTM2 (J17 and J18; 
for DKD vector) were subcloned into the XhoI–XbaI (J14), AscI–RsrII (J17), 
and BstEII–BsiWI (J18) sites. For a TKD vector, the oligonucleotides con-
taining J14, J17, J18, and NL3 (J50) sequences were subcloned into the 
XhoI–XbaI (J14), AscI–RsrII (J17), BstEII–BsiWI (J18), and SbfI–BstBI (J50) 
sites of a TKD vector that contains two human H1 promoters and two   
human U6 promoters. Note that the sequence in LRRTM2 (J33) was reported 
to be potent in knocking down LRRTM2 proteins (de Wit et al., 2009) and 
used in parallel with the other LRRTM shRNA vectors in this study (Fig. 1 B). 
The nucleotide target sequences are as follows (the linker sequences were 
omitted here; sequences that did not work are not included): LRRTM1 (J14), 
5-CAGCCTCAAGTTTCTCGACAT-3;  LRRTM2  (J17),  5-GCTACAACT-
TATAGAGATCCA-3; LRRTM2 (J18), 5-CCAGTATAAGAAGTAGACTTA-3; 
LRRTM2  (J33),  5-TGCTATTCTACTGCGACTCTC-3;  and  NL3  (J50), 
5-GCAGTGTTCTTGCAAGTTA-3.
Production and characterization of recombinant lentiviruses
Recombinant lentiviruses were produced by transfection of human embry-
onic kidney 293T cells with four plasmids, single KD or LRRTM DKD or TKD 
vectors pRRE, pVSVg, and pREV, using FuGENE-6 reagent (Roche) as previ-
ously described (Maximov et al., 2009). pRRE, pVSVg, and pREV encode 
the elements essential for packaging viral particles. Viruses were harvested 
48 h after transfection by collecting the media from transfected HEK293T 
cells, and brief centrifugation at 1,000 g was performed to remove cel-
lular debris. Cultured mouse cortical neurons were infected with 350 µl 
of conditioned cell medium for each 24-well tissue culture dish of high- 
density neurons at DIV4 or 5 and harvested at DIV12 or 13 for quantitative   
RT-PCR analyses using the TaqMan assay kit (Applied Biosystems). The follow-
ing probes for quantitative RT-PCR analyses were purchased from Applied 
Biosystems: LRRTM1 (Mm00551337_g1), LRRTM2 (Mm00997210_g1), 
LRRTM3  (Mm00618457_m1),  LRRTM4  (Mm01185896_m1),  NL3 
(Mm01225951_m1), and glyceraldehyde 3-phosphate dehydrogenase 
(for normalization).
Primary neuronal culture, transfections, immunocytochemistry, image 
acquisition, and analyses
At postnatal day 0 (P0), mouse pups were used to prepare cortical or 
hippocampal  cultures  as  previously  described  (Ko  et  al.,  2009a).  In 
brief, primary tissues from either the cortex or hippocampus from P0 pups 
were dissociated by papain digestion for 20 min at 37°C and plated on 
poly-d-lysine–coated glass coverslips. NL1 KO was previously described 
(Varoqueaux et al., 2006). For RNAi experiments, cultured mouse hippo-
campal neurons (derived from either wild-type or NL1 KO) were trans-
fected by the calcium phosphate method with lentiviral shRNA vectors at 
DIV3 or 9 and immunostained at DIV14 by the antibodies as indicated 
in the figure legends. For infection experiments (Fig. S2, A and B), the 
hippocampal cultured neurons were infected at DIV3 with the indicated 
lentiviruses and immunostained at DIV14. Mouse hippocampal neurons 
at DIV9 or 10 were treated with single or multiple receptor antagonists 
or a channel blocker (L-type calcium channel blocker = 10 µM nifedipine; 
NMDA receptor antagonist = 50 µM APV; non-NMDA receptor antago-
nist = 20 µM NBQX; type II metabotropic glutamate receptor antagonist =   
10 µM LY341495; -aminobutyric acid receptor antagonist = 50 µM pic-
rotoxin; sodium channel blocker = 2 µM TTX; CaM kinase inhibitor and its 
inactive analogue = 5 µM KN-93 and KN-92; and DMSO [negative control]). 
Third, a synapse elimination model seems most appropriate, 
whereby synapses are formed independently of synaptic activity. 
Evidence for this conclusion is also provided by an earlier study 
showing that synaptic activity is not required for the normal wiring 
of the brain (Verhage et al., 2000). The synapse elimination model 
posits that, once formed, synapses are continuously eliminated 
and reformed in an activity-dependent manner as a “proofreading” 
mechanism and that the continuous activity-dependent elimination 
and reformation of synapses require NLs and LRRTMs. This model   
explains why the absence of NLs and LRRTMs causes activity-
dependent synapse elimination, whereas the presence of excess NLs 
and LRRTMs tips the balance between elimination and reformation 
to synapse reformation, causing an increased steady-state number 
of synapses. This model accounts for the puzzling effect that al-
though synapse formation itself is activity independent, refinement 
of synaptic circuits requires changes in synaptic connectivity that is 
activity dependent. In this model, NLs and LRRTMs could either 
be essential for the activity-dependent elimination or reformation 
of synapses or both, but their absence manifests as an activity- 
dependent elimination; hence, the title of this paper. To the best 
of our knowledge, this hypothesis is most consistent with all the 
available data. It is possible that the function of NLs and LRRTMs 
in synapse elimination operates normally in developmental syn-
apse pruning or even participates in experience-dependent remod-
eling of synaptic connectivity, e.g., during learning and memory.
Not surprisingly, our data raise multiple new questions. For 
example, which proteins direct the initial activity-independent for-
mation of synapses, or how is the number of synapses to be formed 
determined? How does the Ca
2+/CaM-dependent pathway mediate 
synapse elimination, and why does synaptic activity translate into 
a loss of synapses instead of a compensatory growth, when NLs 
and LRRTMs are knocked down? Moreover, it is puzzling that 
two classes of molecules with no sequence similarity, NLs and 
LRRTMs, bind to the same presynaptic receptor, neurexins, and 
are functionally redundant at least in activity-dependent synapse 
elimination as we describe here. Is this because of their common 
binding to neurexins and/or a shared postsynaptic signaling path-
way? Independent of the answers to these questions, the emerging 
role for NLs and LRRTMs in the activity-dependent remodeling 
of synapses promises to provide new avenues for understanding 
how synapses in the brain are maintained and modified.
Materials and methods
Construction of expression vectors
4 nts (5-CTACAACTTATAGAGATCCAA-3 to 5-CTACCACGTACAGAG-
ACCCAA-3; the underlined residues were changed) were mutated in 
pGW1-LRRTM2 mVenus vector to make an shRNA-resistant LRRTM2 expres-
sion construct. Residues 38–421 of mouse LRRTM2 (4 nts were mutated) or 
46–695 of rat NL1
AB were PCR amplified and cloned into pDisplay vector 
(Invitrogen) by BglII and SalI digestions. pGW1-LRRTM2 mVenus (a mam-
malian expression vector encoding full-length mouse LRRTM2 fused to 
mVenus), pCMV5-NL1
AB mVenus (a mammalian expression vector encoding 
full-length rat NL1 splice variant containing inserts in splice sites A and B 
fused to mVenus), pCMV5-NL1
AB mVenus (a mammalian expression vector 
encoding full-length rat NL1 splice variant lacking inserts in splice sites 
A and B fused to mVenus), and pCMV5-NL1-32 mVenus (a mammalian 
expression vector encoding full-length rat NL1 splice variant lacking inserts 
in splice sites A and B with five mutated residues critical for neurexin binding 
fused to mVenus) were previously described (see Fig. 3 A for the structural 
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wild-type mouse hippocampal neurons that are either transfected with con-
trol or LRRTM2 DKD vectors or that are infected with control or LRRTM DKD 
lentiviruses. In addition, Fig. S2 displays additional analyses of the TKD 
effects in cultured NL1 KO hippocampal neurons with various pre- and 
postsynaptic markers (in particular, analyses of synapse sizes). Fig. S3 
describes the quantitative analysis of neuronal size and dendritic arboriza-
tion in control NL1 KO and TKD-treated NL1 KO neurons that were stained 
for a somatodendritic marker (MAP2). This figure also shows represen-
tative images and synapse size analyses of NL1 KO neurons that were 
transfected with control and TKD plasmids and analyzed for extended time 
periods (DIV14, DIV17, and DIV20). Fig. S4 depicts representative images 
of the effects of activity blockers on synapse numbers and an analysis of 
chronic stimulation of neurons with 15 mM KCl on synapse numbers and 
sizes (all in control and TKD NL1 KO neurons). Fig. S5 shows nonmerged 
images corresponding to the merged images of Fig. 6 and displays analy-
ses of synapses sizes complementing the analyses of synapse densities 
shown in Figs. 6 and 7. Table S1 summarizes the numerical values ob-
tained  from  the  morphology  experiments  in  this  paper,  as  depicted  in 
the main and supplemental figures, to allow independent assessment of 
raw data. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201101072/DC1.
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The transfected or infected neurons were fixed with 4% PFA/4% sucrose 
for 10 min at room temperature, permeabilized with 0.2% Triton X-100 
in PBS for 5 min at 4°C, blocked with 3% horse serum/0.1% crystalline-
grade BSA in PBS for 30 min at room temperature, and incubated with the 
indicated primary and secondary antibodies in blocking solution for 1 h 
at room temperature, respectively. Surface AMPA receptors were labeled 
in live neurons by a 15-min incubation at 37°C with polyclonal GluR1 
antibody (1:20 in conditioned media, i.e., MEM + 0.5 mM glutamax I; 
EMD) directed against the N terminus of the GluR1 receptor subunit as 
previously described (Beattie et al., 2000), followed by fixation and in-
cubation with donkey anti–rabbit Cy3-conjugated secondary antibodies. 
The following antibodies were used in conventional immunocytochemistry 
experiments: GFP (1:500), MAP2 (1:2,000), synapsin (1:1,000), vGLUT1 
(1:1,000), VGAT (1:500), NMDAR1 (1:100), GluR2 (1:150), and PSD-95   
(1:500). The transfected or infected neurons were randomly chosen and   
acquired using a confocal microscope (LSM510; Carl Zeiss) with 10 or   
63×  objective  lenses  (0.3  and  1.4  NAs,  respectively),  and  all  of  the   
image settings were kept constant. Z-stacked images obtained from con-
focal microscopy were converted to maximal projection and analyzed using 
MetaMorph software (Molecular Devices) with size and density of spines 
and presynaptic terminals. All of the images were separated with different 
color channels (red and green), and red-colored images were transformed 
into an image by grayscale mode in Photoshop (Adobe). After selecting 
one or two primary dendrites from neurons in a single image frame, the 
dendrite lengths were recorded, and dendritic regions of interest were 
manually traced in MetaMorph software and saved for puncta measure-
ments (in a format of rgn files). The constant intensity threshold such that 
diffuse nonsynaptic signals are excluded but synaptic signals are included 
(threshold set level = 90 in the range of 0–255) was applied to all gray 
images. The saved dendritic regions were loaded, calibrated, and mea-
sured by the integrated morphometry analysis menu. For linear density of   
synapses, the total puncta numbers calculated were normalized to 1/50 µm   
dendrite. For spine number measurements, total dendritic protrusions 
(0.5–3.0-µm length) were manually counted in selected dendrites identi-
fied by filling GFP signal and normalized. For synapse size measurement, 
the normalized puncta areas were calculated and exported automatically 
to Excel (Microsoft).
Electrophysiology
Coverslips were transferred to a submerged recording chamber perfused 
with artificial cerebrospinal fluid at room temperature (22–25°C) consisting 
of 122 mM NaCl, 26 mM NaHCO3, 11 mM glucose, 2.5 mM KCl, 2 mM 
CaCl2, 2 mM MgSO4, and 1 mM NaH2PO4. Evoked EPSCs (AMPA or 
NMDA receptor mediated) and IPSCs were recorded from voltage-clamped 
neurons using one of two internal solutions. For EPSC experiments, the 
patch pipette contained 117.5 mM Cs-methanesulfonate, 15.5 mM CsCl,   
10 mM tetraethyl ammonium–Cl, 8 mM NaCl, 10 mM Hepes, 10 mM   
Na-phosphocreatine,  1  mM  MgCl2,  4  mM  ATP-Mg,  0.3  mM  GTP-Na,   
5 mM EGTA, and 1 mM QX-314. For IPSC recordings, the internal solution 
was identical to the one used for EPSCs except that Cs-methanesulfonate 
and CsCl were 95 mM and 55 mM, respectively. Holding potentials were 
as follows: AMPA-EPSC and IPSCs at –70 mV and NMDA-EPSCs at 40 mV. 
Electrode resistances ranged from 2 to 4 M, and series resistances were 
6–12 M after obtaining whole-cell configuration. Synaptic responses were 
elicited by single 90-µA/100-µs current injections (0.1 Hz) via a concentric 
bipolar electrode placed 150 µm away from the soma using a stimulus iso-
lation unit (ISO-Flex; A.M.P.I.). Care was taken to avoid placing the electrode 
over the dendritic field of the recorded neurons. EPSCs were pharmacologi-
cally isolated by adding 50 µM picrotoxin and either 50 µM APV (NMDA 
receptor antagonist) or 10 µM NBQX (non-NMDA receptor antagonist) to 
the external solution. IPSCs were isolated by blocking excitation with both 
APV and NBQX. Recordings were performed using an amplifier (Multiclamp 
700B; Molecular Devices) and custom software written in IGOR Pro (Wave-
metrics), digitized at 10 KHz, filtered at 5 KHz, and analyzed in IGOR Pro.
Statistics
Statistical significance was determined by a Student’s t test only when two 
values  were  compared.  Otherwise,  an  analysis  of  variance  (ANOVA) 
Tukey’s test was used for statistics. For electrophysiology data, unpaired and 
two-tailed Student’s t tests were used. All data shown are means ± SEMs, 
and numerical values for morphometric results are listed in Table S1.
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